Shalini Sharp

Shalini Sharp is currently Chairman at Mahzi Therapeutics, Inc., Independent Director at Neurocrine Biosciences, Inc. since 2020, Director at Alameda County Community Food Bank, Independent Director at Organon & Co. since 2021, Independent Director at Septerna, Inc. since 2024, and Independent Non-Executive Director at BeOne Medicines Ltd. since 2024.
Former roles include Chief Executive Officer at Elan Corp.
Plc from 2001 to 2003, Independent Director at Global Alliance for TB Drug Development from 2015 to 2022, Independent Director at Agenus, Inc. from 2012 to 2018, Independent Director at Array BioPharma, Inc. from 2017 to 2019, Independent Director at Precision BioSciences, Inc. from 2018 to 2022, Independent Director at Sutro Biopharma, Inc. from 2018 to 2023, Independent Director at Mirati Therapeutics, Inc. from 2021 to 2024, Director at Panacea Acquisition Corp.
from 2020 to 2021, Chief of Staff at Elan Pharmaceuticals LLC from 1998 to 2003, Chief Financial Officer & Senior VP-Finance at Ultragenyx Pharmaceutical, Inc. from 2012 to 2020, and Treasurer & Vice President at Dimension Therapeutics, Inc. Education includes an MBA from Harvard Business School and undergraduate studies at Harvard College.